BlueChem Building: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BlueChem Building
Largest movements
- Tangible fixed assets -€244,624
down €244,624 (-3.4%), from €7.2m to €7.0m
- Cash +€93,087
up €93,087 (+19.2%), from €485,439 to €578,525
mainly Depreciation (+€244,624) and Accrued charges and deferred income (+€18,940)
- Investment grants -€90,425
down €90,425 (-3.5%), from €2.6m to €2.5m
- Financial charges -€16,961
down €16,961 (-6.8%), from €250,094 to €233,133
- Gross operating margin -€12,518
down €12,518 (-3.8%), from €327,745 to €315,227
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,747,835 | €7,580,345 | -€167,489 | -2.2% |
| Fixed assets | 21/28 | €7,242,441 | €6,997,818 | -€244,624 | -3.4% |
| Tangible fixed assets | 22/27 | €7,242,441 | €6,997,818 | -€244,624 | -3.4% |
| Land and buildings | 22 | €7,242,441 | €6,997,818 | -€244,624 | -3.4% |
| Current assets | 29/58 | €505,393 | €582,528 | +€77,135 | +15.3% |
| Amounts receivable within one year | 40/41 | €8,041 | €4,003 | -€4,039 | -50.2% |
| Trade receivables | 40 | €8,041 | - | -€8,041 | |
| Other amounts receivable | 41 | €0 | €4,003 | +€4,003 | |
| Cash at bank and in hand | 54/58 | €485,439 | €578,525 | +€93,087 | +19.2% |
| Deferred charges and accrued income | 490/1 | €11,913 | - | -€11,913 | |
| Total equity and liabilities | 10/49 | €7,747,835 | €7,580,345 | -€167,489 | -2.2% |
| Equity | 10/15 | €2,836,730 | €2,703,200 | -€133,530 | -4.7% |
| Contributions | 10/11 | €310,001 | €310,001 | = | 0.0% |
| Capital | 10 | €310,001 | €310,001 | = | 0.0% |
| Issued capital | 100 | €385,000 | €385,000 | = | 0.0% |
| Uncalled capital | 101 | €74,999 | €74,999 | = | 0.0% |
| Reserves | 13 | €3,996 | €3,996 | = | 0.0% |
| Non-distributable reserves | 130/1 | €3,996 | €3,996 | = | 0.0% |
| Legal reserve | 130 | €3,996 | €3,996 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€31,783 | -€74,888 | -€43,105 | -136% |
| Investment grants | 15 | €2,554,516 | €2,464,090 | -€90,425 | -3.5% |
| Provisions and deferred taxes | 16 | €851,505 | €821,364 | -€30,142 | -3.5% |
| Deferred taxes | 168 | €851,505 | €821,364 | -€30,142 | -3.5% |
| Amounts payable | 17/49 | €4,059,599 | €4,055,782 | -€3,817 | -0.1% |
| Amounts payable after more than one year | 17 | €3,811,140 | €3,783,158 | -€27,982 | -0.7% |
| Financial debts | 170/4 | €3,811,140 | €3,783,158 | -€27,982 | -0.7% |
| Amounts payable within one year | 42/48 | €103,328 | €108,552 | +€5,225 | +5.1% |
| Current portion of amounts payable after more than one year | 42 | €94,950 | €94,950 | = | 0.0% |
| Trade debts | 44 | €8,377 | €13,602 | +€5,226 | +62.4% |
| Suppliers | 440/4 | €8,377 | €13,602 | +€5,226 | +62.4% |
| Other amounts payable | 47/48 | €1 | - | -€1 | |
| Accrued charges and deferred income | 492/3 | €145,132 | €164,072 | +€18,940 | +13.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €247,440 | €244,624 | -€2,816 | -1.1% |
| Other operating charges | 640/8 | €1,158 | €1,143 | -€16 | -1.3% |
| Gross operating margin | 9900 | €327,745 | €315,227 | -€12,518 | -3.8% |
| Operating profit (loss) | 9901 | €79,147 | €69,461 | -€9,687 | -12.2% |
| Financial income | 75/76B | €90,425 | €90,425 | -€0 | 0.0% |
| Recurring financial income | 75 | €90,425 | €90,425 | -€0 | 0.0% |
| Financial charges | 65/66B | €250,094 | €233,133 | -€16,961 | -6.8% |
| Recurring financial charges | 65 | €250,094 | €233,133 | -€16,961 | -6.8% |
| Profit (loss) for the period before taxes | 9903 | -€80,521 | -€73,247 | +€7,274 | +9.0% |
| Transfer from deferred taxes | 780 | €30,142 | €30,142 | = | 0.0% |
| Profit (loss) for the period | 9904 | -€50,379 | -€43,105 | +€7,274 | +14.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€50,379 | -€43,105 | +€7,274 | +14.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.